About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. (IDXX) has been publicly traded since 1991, making it a 35-year-old public company. It operates in the Diagnostics & Research industry within the Healthcare sector. The company is headquartered in Westbrook, United States and employs approximately 11,000 people. With a market capitalization of $46 billion, IDXX is a large established company.
Key Statistics
- Current Price
- $573.82
- Market Cap
- $45.82B
- 52-Week High
- $769.98
- 52-Week Low
- $356.14
- Sector
- Healthcare
- Industry
- Diagnostics & Research
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -15.18% | $676.53 | $573.82 |
| 2025 | +63.63% | $413.44 | $676.53 |
| 2024 | -25.51% | $555.05 | $413.44 |
| 2023 | +36.06% | $407.96 | $555.05 |
| 2022 | -38.04% | $658.46 | $407.96 |
| 2021 | +31.73% | $499.87 | $658.46 |
| 2020 | +91.43% | $261.13 | $499.87 |
| 2019 | +40.38% | $186.02 | $261.13 |
| 2018 | +18.95% | $156.38 | $186.02 |
| 2017 | +33.35% | $117.27 | $156.38 |
| 2016 | +60.82% | $72.92 | $117.27 |
| 2015 | -1.64% | $74.14 | $72.92 |
| 2014 | +39.39% | $53.19 | $74.14 |
| 2013 | +14.62% | $46.40 | $53.19 |
| 2012 | +20.58% | $38.48 | $46.40 |
| 2011 | +11.18% | $34.61 | $38.48 |
| 2010 | +29.50% | $26.73 | $34.61 |
| 2009 | +48.14% | $18.04 | $26.73 |
| 2008 | -38.46% | $29.32 | $18.04 |
| 2007 | +47.87% | $19.83 | $29.32 |
| 2006 | +10.17% | $18.00 | $19.83 |
| 2005 | +31.86% | $13.65 | $18.00 |
| 2004 | +17.96% | $11.57 | $13.65 |
| 2003 | +40.88% | $8.21 | $11.57 |
| 2002 | +15.22% | $7.13 | $8.21 |
| 2001 | +29.59% | $5.50 | $7.13 |
| 2000 | +36.43% | $4.03 | $5.50 |
| 1999 | -40.07% | $6.73 | $4.03 |
| 1998 | +68.82% | $3.98 | $6.73 |
| 1997 | -55.73% | $9.00 | $3.98 |
| 1996 | -23.40% | $11.75 | $9.00 |
| 1995 | +161.11% | $4.50 | $11.75 |
| 1994 | +12.94% | $3.98 | $4.50 |
| 1993 | +94.66% | $2.05 | $3.98 |
| 1992 | +47.19% | $1.39 | $2.05 |
Valuation
IDXX currently trades at a trailing P/E ratio of 43.9, which is considered high relative to the broader market. The forward P/E of 34.9 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 28.5. The price-to-sales ratio is 10.6.
Dividends
IDEXX Laboratories, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
IDXX has a beta of 1.70, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $356.14 to $769.98, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 13 analyst opinions, IDXX has a consensus "buy" rating. The average price target of $750.23 suggests 30.7% upside from current levels.
Frequently Asked Questions
What does IDEXX Laboratories, Inc. do? ▼
IDEXX Laboratories, Inc. is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in Westbrook, United States.
What sector is IDXX in? ▼
IDXX operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
When did IDXX go public? ▼
IDEXX Laboratories, Inc. went public in 1991, making it a 35-year-old public company as of 2026.
How much would $1,000 invested in IDXX 5 years ago be worth today? ▼
A $1,000 investment in IDXX five years ago would be worth approximately $1,163 today, representing a 16.3% return.
Does IDXX pay dividends? ▼
No, IDEXX Laboratories, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is IDXX's market cap? ▼
IDEXX Laboratories, Inc. has a market capitalization of $46 billion, classifying it as a large-cap company.
What is IDXX's P/E ratio? ▼
IDXX has a trailing P/E ratio of 43.9 and a forward P/E of 34.9, which measures how much investors are paying per dollar of earnings.
Is IDXX a buy, hold, or sell? ▼
Based on 13 opinions, IDXX has a consensus "buy" rating. The average price target is $750.23.
Last updated: 3/14/2026